SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company; Vasogen Also Raises $7.5 Million